| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 05/29/2002 | EP1208198A2 Egfh2 genes and gene products |
| 05/29/2002 | EP1208197A1 Iren protein, its preparation and use |
| 05/29/2002 | EP1208196A1 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof |
| 05/29/2002 | EP1208195A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 05/29/2002 | EP1208194A2 Drug target isogenes: polymorphisms in the immunoglobulin e receptor i alpha subunit gene |
| 05/29/2002 | EP1208192A1 Method for producing a heterologous secreted protein from chinese hamster ovary cells grown on microcarriers |
| 05/29/2002 | EP1208191A1 13 human colon and colon cancer associated proteins |
| 05/29/2002 | EP1208190A1 Rapid growing microorganisms for biotechnology applications |
| 05/29/2002 | EP1208111A2 Genes encoding insect odorant receptors and uses thereof |
| 05/29/2002 | EP1207736A1 Method for induction synthesis of heat stress proteins (hsp) & production from herbaceous plants |
| 05/29/2002 | EP1002095B1 Improved protein expression strains |
| 05/29/2002 | EP0889971B1 Phosphatase modulator |
| 05/29/2002 | DE10056899A1 New promoter from Saccharomyces cerevisiae YNL279W gene, useful e.g. for identifying modulators of G protein-coupled receptors, is responsive to pheromone alpha |
| 05/29/2002 | CN1351664A DNA sequence and recombination production of a graminae allergen |
| 05/29/2002 | CN1351661A Compounds |
| 05/29/2002 | CN1351653A Anti-bacterial vaccine compositions |
| 05/29/2002 | CN1351614A Human antibodies that bind human IL-12 and methods for producing |
| 05/29/2002 | CN1351612A Novel organic anion transport proteins |
| 05/29/2002 | CN1351174A Inhibiting material for inverting enzyme for angiotensin I |
| 05/29/2002 | CN1351083A Process for preparing collagen |
| 05/29/2002 | CN1351082A Human protein with cancer cell growth promoting function and its coding sequence |
| 05/29/2002 | CN1351081A Human protein with cancer cell growth suppressing function and its coding sequence |
| 05/29/2002 | CN1351080A Human protein with cancer call growth suppressing function and its coding sequence |
| 05/29/2002 | CN1351079A Human protein with cancer cell growth suppressing function and its coding sequence |
| 05/28/2002 | US6395959 Nucleotide sequence encoding the enzyme I SceI and the use thereof |
| 05/28/2002 | US6395884 Purifying human alpha galactosidase from human cells by passing cells over a hydrophobic interaction resin; therapy for fabry's disease |
| 05/28/2002 | US6395882 Selectin ligands |
| 05/28/2002 | US6395877 14273 receptor, a novel G-protein coupled receptor |
| 05/28/2002 | US6395707 Methods of treatment utilizing variants of vascular endothelial cell growth factor |
| 05/28/2002 | US6395538 Method and system for providing real-time, in situ biomanufacturing process monitoring and control in response to IR spectroscopy |
| 05/28/2002 | US6395532 Modified enzymes and their use for peptide synthesis |
| 05/28/2002 | US6395530 LLG polypeptides of the triacylglycerol lipase family, and compositions and methods for their use in enzymatic hydrolysis, and protein and gene therapies |
| 05/28/2002 | US6395523 Adjusting activity of enzymatic polypeptides; obtain cell, insert expression vector, monitor activity of expressed polypeptide |
| 05/28/2002 | US6395515 Directed switch-mediated DNA recombination |
| 05/28/2002 | US6395513 Clostridial toxin derivatives able to modify peripheral sensory afferent functions |
| 05/28/2002 | US6395511 Nuclelotide sequences coding regulatory protein; for usein treatment of bone disorders |
| 05/28/2002 | US6395510 Vertebrate apoptosis gene: compositions and methods |
| 05/28/2002 | US6395500 Antibodies for the detection of beer spoilage lactic acid bacteria and kit employing the antibodies |
| 05/28/2002 | US6395499 Methods of identifying modulators of a DP prostaglandin receptor |
| 05/28/2002 | US6395498 Methods of identifying compounds that modulate body weight using the OB receptor |
| 05/28/2002 | US6395497 Suppression of leukocyte transferring in humans; administer immunoglobulins to humans, detect bound receptor, evaluate immune response |
| 05/28/2002 | US6395478 Identification and comparison of protein-protein interactions that occur in populations and indentification of inhibitors of these interactors |
| 05/28/2002 | US6395283 Equine herpesvirus type 1 glyocoprotein D (EHV-1gD) |
| 05/28/2002 | US6395275 Synthetic human neutralizing monoclonal antibodies to human immunodeficiency virus |
| 05/28/2002 | US6395272 Therapeutic compounds comprised of anti-Fc receptor antibodies |
| 05/28/2002 | US6395267 Inhibiting signal transduction in tumor necrosis factor receptors by identifying molecule that binds to specific amino acid sequence of human receptor, then bringing molecule in contact with receptor |
| 05/28/2002 | CA2121256C Secreted mac-2-binding glycoprotein |
| 05/28/2002 | CA2092533C Nucleotide sequences coding for a human protein with angiogenesis regulative properties |
| 05/28/2002 | CA2032653C Cytotoxic lymphocyte maturation factor and monoclonal antibodies directed thereto |
| 05/28/2002 | CA1341363C Insulinotropic hormone |
| 05/28/2002 | CA1341362C Human manganese superoxide dismutase cdna, its expression in bacteria and method of recovering enzymatically active human manganese superoxide dismutase |
| 05/23/2002 | WO2002040697A2 Metabolic rate shifts in fermentations expressing recombinant proteins |
| 05/23/2002 | WO2002040696A2 Methods for large scale protein production in prokaryotes |
| 05/23/2002 | WO2002040695A1 Method for mass-producing human ferritin using recombinant nethylotropic yeasts |
| 05/23/2002 | WO2002040688A2 Maize yellow stripe1 and related genes |
| 05/23/2002 | WO2002040686A2 Expression system for recombinant proteins |
| 05/23/2002 | WO2002040676A2 Mutant allergens |
| 05/23/2002 | WO2002040671A2 Immunoglobulin superfamily proteins |
| 05/23/2002 | WO2002040666A2 Fat regulated genes, uses thereof, and compounds for modulating same |
| 05/23/2002 | WO2002040660A2 Promoter for the functional characterisation of g-protein coupled receptors in the yeast saccharomyces cerevisiae |
| 05/23/2002 | WO2002040652A2 Novel soluble endoproteases for the in vitro processing of recombinant proteins |
| 05/23/2002 | WO2002040650A2 Methods for large scale production of recombinant dna-derived tpa or k2s molecules |
| 05/23/2002 | WO2002040541A2 Transporters and ion channels |
| 05/23/2002 | WO2002040535A2 Compositions and methods relating to ovary specific genes and proteins |
| 05/23/2002 | WO2002040515A2 Exoenzyme toxin of aeromonas salmonicida, and uses thereof |
| 05/23/2002 | WO2002040514A2 Type iii secretion pathway in aeromonas salmonicida, and uses therefor |
| 05/23/2002 | WO2002040509A1 Antibody against norwalk virus and method of detecting virus by using the antibody |
| 05/23/2002 | WO2002040506A2 Modified clostridial neurotoxins with altered biological persistence |
| 05/23/2002 | WO2002040497A1 In vitro protein synthesis using glycolytic intermediates as an energy source |
| 05/23/2002 | WO2002040041A2 Orally ingestible preparation of mistletoe lectins and method |
| 05/23/2002 | WO2002015931A9 Immunologic method for the prevention of dental caries |
| 05/23/2002 | WO2001090182A3 Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid beta for induction of an immune response to amyloid beta and amyloid deposits |
| 05/23/2002 | WO2001088117A3 In vitro fucosylation recombinant glycopeptides |
| 05/23/2002 | WO2001085911A3 Chromosome 17p-linked prostate cancer susceptibility gene and a paralog and orthologous genes |
| 05/23/2002 | WO2001085792A8 Mu-1, member of the cytokine receptor family |
| 05/23/2002 | WO2001081577A3 Dna encoding the prost 03 polypeptide |
| 05/23/2002 | WO2001073028A3 A p-selectin glycoprotein ligand (psgl-1) binding protein and uses therefor |
| 05/23/2002 | WO2001064837A8 β NETRIN AND USES THEREOF |
| 05/23/2002 | WO2001040271A9 Cancer associated antigens and uses therefor |
| 05/23/2002 | WO2001029197A3 Novel germinal center kinase cell cycle proteins, compositions and methods of use |
| 05/23/2002 | US20020062488 Methods and compositions for modulating the interaction between the apj receptor and the hiv virus |
| 05/23/2002 | US20020062010 Generating polyclonal antibody; obtain cells, transform cell with expression vector coding preferential polypeptides, culture cells recover polyclonal antibody |
| 05/23/2002 | US20020062009 Monoclonal antibodies with reduced immunogenicity |
| 05/23/2002 | US20020062008 Novel human beta2 integrin alpha subunit |
| 05/23/2002 | US20020061834 Human G-protein Chemokine receptor (CCR5) HDGNR10 |
| 05/23/2002 | US20020061581 Nuclelotide sequences coding immunoglobulin segment; for use in diagnosis and prevention of viral infection and disease |
| 05/23/2002 | US20020061569 Nuclelotide sequences for use in the prevention of proliferation of microorganisms |
| 05/23/2002 | US20020061567 Nucleotide sequences coding polypeptide for use in diagnostics, forensics, gene mapping and detection of mutation |
| 05/23/2002 | US20020061560 Nucleotide sequences for use as tools in the generation of heterologous proteinsin culture |
| 05/23/2002 | US20020061559 Preferential protein for use in the diagnosis and treatment of cancers; antitumor agents; anticarcinogeneic agents |
| 05/23/2002 | US20020061553 Partners of the PTB1 domain of FE65, preparation and uses |
| 05/23/2002 | US20020061545 Streptococcus pneumoniae antigens and vaccines |
| 05/23/2002 | US20020061524 Alterations in the long QT syndrome genes KVLQT1 and SCN5A and methods for detecting same |
| 05/23/2002 | US20020061521 Nucleic acids, proteins, and antibodies |
| 05/23/2002 | US20020061517 Adenovirus carrying gag gene HIV vaccine |
| 05/23/2002 | US20020061513 Isolation of preferential cellular components; obtain genetically engineered cells, express vector, detect polypeptides on support, recover polypeptides |
| 05/23/2002 | US20020061316 Immunotherapeutic stress protein-peptide complexes against cancer |
| 05/23/2002 | US20020061309 Production of peptides in plants as N-terminal viral coat protein fusions |
| 05/23/2002 | US20020061307 Polyalkylene oxide-modified single chain polypeptides |
| 05/23/2002 | US20020061306 DNA sequences encoding proteins having ability to bind alpha 2-macroglobulin; expression vectors; immunology |